← Back
$RCUS All transactions

Arcus Biosciences, Inc.

A

$ Value

$0

Shares

38,300

Price

$0

Filed

Jun 12

Insider

Name

PERLMAN ANDREW J

Title

CIK

0001201617

Roles

Director

Transaction Details

Transaction Date

2025-06-10

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

38,300

Footnotes

Represents the grant of restricted stock units that vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. | The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.

Filing Info

Accession No.

0001724521-25-000092

Form Type

4

Issuer CIK

0001724521

PERLMAN ANDREW J's History

Date Ticker Type Value
2025-06-10 RCUS A $0
2025-06-10 RCUS A $0

Other Insiders at RCUS (90d)

Insider Bought Sold Last
ROSEN TERRY J
Chief Executive Officer
2026-01-23
Jaen Juan C.
President
2026-01-23
Goeltz II Robert C.
Chief Financial Officer
2026-01-23
Jarrett Jennifer
Chief Operating Officer
2026-01-23
Azoy Alexander
Chief Accounting Officer
2026-01-23
Tang Carolyn C.
General Counsel
2026-01-23
Markus Richard
Chief Medical Officer
2026-01-23